tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Petusky, 322 are a BUY (89.69%), 34 are a HOLD (9.47%), 3 are a SELL (0.84%).
Analyst Michael Petusky, currently employed at BARRINGTON, carries an average stock price target met ratio of 56.99% that have a potential upside of 26.95% achieved within 255 days.
Michael Petusky’s has documented 698 price targets and ratings displayed on 23 stocks. The coverage is on Healthcare, Consumer Defensive, Technology, Utilities sectors.
Most recent stock forecast was given on HAE, Haemonetics at 18-Aug-2026.
Analyst best performing recommendations are on VRME (VERIFYME).
The best stock recommendation documented was for VRME (VERIFYME) at 3/29/2023. The price target of $2 was fulfilled within 5 days with a profit of $0.43 (27.39%) receiving and performance score of 54.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Jul-2025
$21
$-0.78 (-3.58%)
$16
Buy Since 03-Nov-2023
$17
$1.9 (12.58%)
$16
Hold Since 14-Oct-2022
$24
$8.9 (58.94%)
$23
Buy Since 22-Feb-2019
$32
$17.24 (116.80%)
$41
Buy Since 15-Nov-2021
$35
$20.24 (137.13%)
$55
Which stock is Michael Petusky is most bullish on?
Which stock is Michael Petusky is most reserved on?
What Year was the first public recommendation made by Michael Petusky?
